<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Mesoscopic Fluorescence Tomography of a Photosensitizer (HPPH) 3D Biodistribution in Skin Cancer" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/mesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/mesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-01-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Mesoscopic Fluorescence Tomography of a Photosensitizer (HPPH) 3D Biodistribution in Skin Cancer" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-01-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Mesoscopic Fluorescence Tomography of a Photosensitizer (HPPH) 3D Biodistribution in Skin Cancer","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/mesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer/"},"url":"https://clinicaltree.github.io/posts/mesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer/"}</script><title>Mesoscopic Fluorescence Tomography of a Photosensitizer (HPPH) 3D Biodistribution in Skin Cancer | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Mesoscopic Fluorescence Tomography of a Photosensitizer (HPPH) 3D Biodistribution in Skin Cancer</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Mesoscopic Fluorescence Tomography of a Photosensitizer (HPPH) 3D Biodistribution in Skin Cancer</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1391187600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jan 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Mehmet S. Ozturk RPI</a> </em>, <em> <a href="">Daniel Rohrbach RPCI</a> </em>, <em> <a href="">Ulas Sunar PhD</a> </em>, <em> <a href="">Xavier Intes PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2135 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Photodynamic therapy (PDT) is a promising strategy for treating cancer. PDT involves three components: a photosensitizer (PS) drug, a specific wavelength of drug-activating light, and oxygen. A challenge in PDT is the unknown biodistribution of the PS in the target tissue. In this preliminary study, we report the development of a new approach to image in three dimensions the PS biodistribution in a noninvasive and fast manner.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A mesoscopic fluorescence tomography imaging platform was used to image noninvasively the biodistribution of 2-[1-hexyloxyethyl]-2 devinyl pyropheophorbide-a (HPPH) in preclinical skin cancer models. Seven tumors were imaged and optical reconstructions were compared to nonconcurrent ultrasound data.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Successful imaging of the HPPH biodistribution was achieved on seven skin cancer tumors in preclinical models with a typical acquisition time of 1 minute. Two-dimensional fluorescence signals and estimated three-dimensional PS distributions were located within the lesions. However, HPPH distribution was highly heterogeneous with the tumors. Moreover, HPPH distribution volume and tumor volume as estimated by ultrasound did not match.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The results of this proof-of-concept study demonstrate the potential of MFMT to image rapidly the HPPH three-dimensional biodistribution in skin cancers. In addition, these preliminary data indicate that the PS biodistribution in skin cancer tumors is heterogeneous and does not match anatomical data. Mesoscopic fluorescence molecular tomography, by imaging fluorescence signals over large areas with high spatial sampling and at fast acquisition speeds, may be a new imaging modality of choice for planning and optimizing of PDT treatment.</p><p>The most common cancer treatments include surgery, radiation therapy, chemotherapy, immunotherapy, and monoclonal antibody therapy. These therapies may be used either alone or in combination with other therapies. Although improvement of these treatment modalities to enhance their tumor selectivity is under way, development of novel alternative treatment approaches that may be safer, reduce functional tissue damage, and improve patients’ quality of life is a major focus area of research. Among all new modalities investigated, photodynamic therapy (PDT) emerges as a promising alternative treatment strategy . PDT is a noninvasive treatment using a combination of a photosensitizer (PS) drug, a specific wavelength of drug-activating light and oxygen. Light activation of a PS results in energy transfer cascades that ultimately yield cytotoxic reactive oxygen species.</p><p>PDT has undergone extensive investigations in cancer treatment and various PS drugs have been approved for clinical use in the United States and other countries . PDT is being used mainly to treat skin diseases and easily accessible malignant and premalignant lesions . PDT is a local therapy with the major advantage that the PS itself is minimally toxic in the absence of light; therefore, PS accumulation in nonspecific tissues confers minimal systemic toxicity. Furthermore, light activation is performed below the maximum permissible exposure limit and at wavelengths that do not harm the tissues. Hence, PDT can be applied repeatedly should a single treatment fail. The efficacy of PDT is largely dependent on the functional state of the tissue, the PS uptake, and light fluence delivered locally. If these parameters can be controlled/assessed relatively easily in superficial lesions, it is a significant challenge for pathologies that are thick or located a few millimeters deep. In such scenarios, the PS biodistribution profile in tissue is not homogeneous, even in the case of local topical application. Second, light propagation in tissues is highly affected by the optical properties distribution in the sample. Hence, PDT efficiency can be hampered by intralesion PS heterogeneous biodistribution and light flux profiles.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="preclinical-model-protocol"><span class="mr-2">Preclinical Model Protocol</span><a href="#preclinical-model-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="tumor-imaging"><span class="mr-2">Tumor Imaging</span><a href="#tumor-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/0_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/0_1s20S1076633213005424.jpg" alt="Figure 1, (a) The tail of the animal was immersed in a matching liquid. Raster scanning was applied on the tumor area ( inset ). (b) Laser diode excites the fluorophore by raster scanning over a 6 × 3 mm 2 area. Emission signal descanned and directed onto detector array with a beam splitter (BS) followed by an emission filter." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mesoscopic-fluorescence-imaging-system"><span class="mr-2">Mesoscopic Fluorescence Imaging System</span><a href="#mesoscopic-fluorescence-imaging-system" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mfmt-reconstructions"><span class="mr-2">MFMT Reconstructions</span><a href="#mfmt-reconstructions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>x’=(ATA+λD)−1ATb x</p><p>’</p><p>=</p><p>(</p><p>A</p><p>T</p><p>A</p><p>+</p><p>λ</p><p>D</p><p>)</p><p>−</p><p>1</p><p>A</p><p>T</p><p>b</p><p>where <em>b</em> is obtained from the fluorescence measurement, <em>x′</em> is the reconstructed fluorescence distribution, <em>λD</em> is a regularization depth-dependent parameter, and <em>A</em> is the whole Jacobian that is computed based by the Monte Carlo–forward model. Thanks to the symmetry of the imaging space, <em>A</em> is populated for all the positions of the raster-scanned beam, based on a single set of sensitivity matrices, which are computed for one optode set (one source and seven detectors). Optical properties, μ s ′ and μ a for Jacobian ( <em>A</em> ) matrix are chosen as 3 mm −1 and 0.002 mm −1 , respectively. Both 3D reconstruction of absorption and/or fluorescence contrast can be performed using this model . A depth-dependent regularization technique is used to mitigate the ill-posedness of the reflectance geometry. <em>D</em> is a diagonal matrix whose elements are the square root of the corresponding diagonal elements of <em>A__T__A</em> . The scaling factor (λ) for this diagonal matrix is selected based on the L-curve analysis . The conjugate gradient method is applied to solve this linear system (function <em>cgs</em> , MATLAB R2009b, MathWorks, Natick, MA). The iterative algorithm was stopped if 100 iterations or if a tolerance of 10 −2 was reached. Overall, the Monte Carlo–forward model and optical reconstructions were computed in less than 4 minutes for the typical 106,400 data measurements (15,200 sources positions × seven detectors) on a personal computer (Intel Core i7-3820 central processor unit, 3.6 GHz, 64 GB).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ultrasound-imaging"><span class="mr-2">Ultrasound Imaging</span><a href="#ultrasound-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="co-registration-of-us-and-mfmt-data-sets"><span class="mr-2">Co-registration of US and MFMT Data Sets</span><a href="#co-registration-of-us-and-mfmt-data-sets" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/1_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/1_1s20S1076633213005424.jpg" alt="Figure 2, A clear inclusion (PDMS) was depicted in (a) ; cylinder inclusion allowed a hollow opening to host a capillary. Depending on the depth of the hole, we arranged the fluorescence inclusion position in the PDMS. (b) A phantom was cut with a scalpel over the scanning area ( red rectangle ). Inclusion was positioned ( dashed rectangle ) before solidification of agar solution. (c) Raw data demonstrate three different localized fluorescence signals in the phantom through the inclusion as acquired by Detector 1. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/2_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/2_1s20S1076633213005424.jpg" alt="Figure 3, (a) Ultrasound A-scan image shows the membrane that separates the transducer media from the outside (membrane), tumor area, and the skin of the tail (scale bar, 1 mm). (b) Segmentation was performed based on thresholding at 10% of maximum intensity thanks to high contrast between tumor and the surrounding area. (c) The same slice of ultrasound (US) and mesoscopic fluorescence molecular tomography (MFMT) reconstruction was overlaid to show the correspondence with each other. (d) The cross-section of the reconstructed images was shown together; tail ( gray ), US ( blue ), and MFMT ( red ); white border shows the segmentation boundary for a US slice (a) and a segmented slice (b) . For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-and-discussion"><span class="mr-2">Results and discussion</span><a href="#results-and-discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="phantom-study-results"><span class="mr-2">Phantom Study Results</span><a href="#phantom-study-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/3_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/3_1s20S1076633213005424.jpg" alt="Figure 4, Mesoscopic fluorescence molecular tomography reconstruction ( red ) overlaid with the segmented ultrasound images. (a) Case 1: Fluorescence-filled capillary placed through the hollow opening ( yellow ) inside the inclusion ( green ). Inclusion placed just beneath the matrix ( blue ) surface. (b) Case 2: Inclusion ( green ) is adjacent to the fluorescence dye–filled capillary. (c) Case 3: Fluorescent capillary placed at the top part of the inclusion and placed at the edge of the phantom. Yellow dashed area represents the interrogation area. Scale bar, 1 mm. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="tumor-imaging-results"><span class="mr-2">Tumor Imaging Results</span><a href="#tumor-imaging-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/4_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/4_1s20S1076633213005424.jpg" alt="Figure 5, Background subtracted raw data for the no tumor tail and seven different tumors. (a) First-detector raw data; (b) second-detector raw data. Both detectors deliver high-contrast and highly localized signal. Images show a 3 × 6 mm 2 scanning area." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mfmt-reconstructions-and-us-co-registration"><span class="mr-2">MFMT Reconstructions and US Co-registration</span><a href="#mfmt-reconstructions-and-us-co-registration" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/5_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/5_1s20S1076633213005424.jpg" alt="Figure 6, Both ultrasound (US; blue ) and mesoscopic fluorescence molecular tomography (MFMT; red ) was used to generate this three-dimensional image of the tumor. US data also shows the tail structure ( pink ). MFMT data were acquired by raster scanning a 6 × 3 mm 2 area over the tail; a 20% isosurface value (ISO) value used to visualize the MFMT image (a) . The top view (b) shows the overlay of two reconstructions and the scanning area ( orange box ). (c) Interrogation depth and depth co-registration is shown. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/6_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/6_1s20S1076633213005424.jpg" alt="Figure 7, Ultrasound reconstruction overlaid with the (a) first and (b) second detectors. Black lines are the tail boundary. Scale bar, 1 mm." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/7_1s20S1076633213005424.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MesoscopicFluorescenceTomographyofaPhotosensitizerHPPH3DBiodistributioninSkinCancer/7_1s20S1076633213005424.jpg" alt="Figure 8, All tumors are shown in increasing volume order according to the ultrasound (US) volume estimation. Tail ( gray ), US tumor ( blue ), and mesoscopic fluorescence molecular tomography tumor ( red ) are all in shown in same scale. Scale bar, 1 mm. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article." class="lazyload" data-proofer-ignore></a></p><p>Table 1</p><p>Ultrasound and MFMT Reconstructed Tumor Volumes</p><p>Volume (mm 3 ) US 10% ISO 20% ISO 30% ISO 40% ISO Tumor 1 0.22 2.35 1.58 0.66 0.31 Tumor 2 2.8 4 1.98 1.26 0.85 Tumor 3 4.18 5.8 3.4 2 1.3 Tumor 4 4.8 3.11 1.44 0.77 0.38 Tumor 5 8.11 12 7.2 6.15 3.4 Tumor 6 9.6 11.3 5 2.16 0.6 Tumor 7 10 6.7 4.4 2.6 1.5</p><p>ISO, isosurface value for MFMT reconstruction.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Dolmans D.E., Fukumura D., Jain R.K.: Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3: pp. 380-387.</p><li><p>2. Ormond A., Freeman H.: Dye sensitizers for photodynamic therapy. Materials (Basel) 2013; 6: pp. 817-840.</p><li><p>3. Tian Y.Y., Wang L.L., Wang W.: Progress in photodynamic therapy on tumors. Laser Phys 2008; 18: pp. 1119-1123.</p><li><p>4. Morton C.A., Szeimies R.M., Sidoroff A., et. al.: European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen’s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: pp. 536-544.</p><li><p>5. Green B., Cobb A.R., Hopper C.: Photodynamic therapy in the management of lesions of the head and neck. Br J Oral Maxillofac Surg 2013; 51: pp. 283-287.</p><li><p>6. Kaščáková S., Kruijt B., de Bruijn H.S., et. al.: Ex vivo quantification of mTHPC concentration in tissue: Influence of chemical extraction on the optical properties. J Photochem Photobiol B Biol 2008; 91: pp. 99-107.</p><li><p>7. Mo W., Rohrbach D., Sunar U.: Imaging a photodynamic therapy photosensitizer in vivo with a time-gated fluorescence tomography system. J Biomed Opt 2012; 17: pp. 71306.</p><li><p>8. Muffoletto D., Gupta A., Xu Z., et. al.: Imaging of a targeted PDT drug with fluorescence tomography. Proc SPIE 2009; 7164: 716409–716409</p><li><p>9. Kepshire D., Davis S.C., Dehghani H., et. al.: Fluorescence tomography characterization for sub-surface imaging with protoporphyrin IX. Opt Express 2008; 16: pp. 8581-8593.</p><li><p>10. Cauchon N., Turcotte E., Lecomte R., et. al.: Predicting efficacy of photodynamic therapy by real-time FDG-PET in a mouse tumour model. Photochem Photobiol Sci 2012; 11: pp. 364-370.</p><li><p>11. Celli J.P., Spring B.Q., Rizvi I., et. al.: Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010; 110: pp. 2795-2838.</p><li><p>12. Doiron DR, Gomer CJ. Porphyrin Localization and Treatment of Tumors. Proceedings of the Clayton Foundation International Symposium on Porphyrin Localization and Treatment of Tumors, Santa Barbara, CA, April 24-28, 1983. New York: A.R. Liss, 1984.</p><li><p>13. Sunar U., Rohrbach D.J., Morgan J., et. al.: Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging. Biomed Opt Express 2013; 4: pp. 531-537.</p><li><p>14. Wilson B.C., Andersson-Engels S.: In vivo fluorescence in clinical oncology: fundamental and practical issues. J Cell Pharmacol 1991; 3: pp. 48-61.</p><li><p>15. Balas C.: Review of biomedical optical imaging—a powerful, non-invasive, non-ionizing technology for improving in vivo diagnosis. Meas Sci Technol 2009; 20: pp. 104020.</p><li><p>16. Pogue B.W., Burke G.: Fiber-optic bundle design for quantitative fluorescence measurement from tissue. Appl Opt 1998; 37: pp. 7429-7436.</p><li><p>17. Lee C.C., Pogue B.W., O’Hara J.A., et. al.: Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B. Photochem Photobiol Sci 2003; 2: pp. 145.</p><li><p>18. De Rosa F.S., Marchetti J.M., Thomazini J.A., et. al.: A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin {IX} accumulation determined by confocal microscopy. J Control Release 2000; 65: pp. 359-366.</p><li><p>19. König K.: Multiphoton microscopy in life sciences. J Microsc 2000; 200: pp. 83-104.</p><li><p>20. Zhao L., Lee V.K., Yoo S.S., et. al.: The integration of 3-D cell printing and mesoscopic fluorescence molecular tomography of vascular constructs within thick hydrogel scaffolds. Biomaterials 2012; 33: pp. 5325-5332.</p><li><p>21. Yuan S., Li Q., Jiang J., et. al.: Three-dimensional coregistered optical coherence tomography and line-scanning fluorescence laminar optical tomography. Opt Lett 2009; 34: pp. 1615-1617.</p><li><p>22. Muldoon T.J., Burgess S.A., Chen B.R., et. al.: Analysis of skin lesions using laminar optical tomography. Biomed Opt Express 2012; 3: pp. 1701-1712.</p><li><p>23. Ozturk M.S., Lee V.K., Zhao L., et. al.: Mesoscopic fluorescence molecular tomography of reporter genes in bioprinted thick tissue. J Biomed Opt 2013; 18: pp. 100501.</p><li><p>24. Dreier J., Felderer L., Barysch M., et. al.: Basal cell carcinoma: a paradigm for targeted therapies. Expert Opin Pharmacother 2013; 14: pp. 1307-1318.</p><li><p>25. Allison R.R., Downie G.H., Cuenca R., et. al.: Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther 2004; 1: pp. 27-42.</p><li><p>26. Schmitt J.M., Kumar G.: Optical scattering properties of soft tissue: a discrete particle model. Appl Opt 1998; 37: pp. 2788-2797.</p><li><p>27. Li H., Tian J., Zhu F., et. al.: A mouse optical simulation environment (MOSE) to investigate bioluminescent phenomena in the living mouse with the Monte Carlo method. Acad Radiol 2004; 11: pp. 1029-1038.</p><li><p>28. Dunn A., Boas D.: Transport-based image reconstruction in turbid media with small source-detector separations. Opt Lett 2000; 25: pp. 1777-1779.</p><li><p>29. Björn S., Ntziachristos V., Schulz R.: Mesoscopic epifluorescence tomography: reconstruction of superficial and deep fluorescence in highly-scattering media. Opt Express 2010; 18: pp. 8422-8429.</p><li><p>30. Yuan B., Burgess S.A., Iranmahboob A., et. al.: A system for high-resolution depth-resolved optical imaging of fluorescence and absorption contrast. Rev Sci Instrum 2009; 80: pp. 043706.</p><li><p>31. Chen J., Intes X.: Comparison of Monte Carlo methods for fluorescence molecular tomography-computational efficiency. Med Phys 2011; 38: pp. 5788-5798.</p><li><p>32. Intes X., Ripoll J., Chen Y., et. al.: In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys 2003; 30: pp. 1039.</p><li><p>33. Flynn BP, D’Souza AV, Kanick SC, et al. Subsurface PpIX imaging in vivo with ultrasound-guided tomographic spectroscopy: reconstruction vs. born-normalized data. 2013; 8568:856807–856809.</p><li><p>34. Rohrbach D.J., Rigual N., Tracy E., et. al.: Interlesion differences in the local photodynamic therapy response of oral cavity lesions assessed by diffuse optical spectroscopies. Biomed Opt Express 2012; 3: pp. 2142-2153.</p><li><p>35. Saager R.B., Cuccia D.J., Saggese S., et. al.: Quantitative fluorescence imaging of protoporphyrin IX through determination of tissue optical properties in the spatial frequency domain. J Biomed Opt 2011; 16: pp. 126013.</p><li><p>36. Konecky S.D., Mazhar A., Cuccia D., et. al.: Quantitative optical tomography of sub-surface heterogeneities using spatially modulated structured light. Opt Express 2009; 17: pp. 14780-14790.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-2/'>Issue 2</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Mesoscopic%20Fluorescence%20Tomography%20of%20a%20Photosensitizer%20(HPPH)%203D%20Biodistribution%20in%20Skin%20Cancer%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Mesoscopic%20Fluorescence%20Tomography%20of%20a%20Photosensitizer%20(HPPH)%203D%20Biodistribution%20in%20Skin%20Cancer%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmesoscopic-fluorescence-tomography-of-a-photosensitizer-hpph-3d-biodistribution-in-skin-cancer%2F&text=Mesoscopic%20Fluorescence%20Tomography%20of%20a%20Photosensitizer%20(HPPH)%203D%20Biodistribution%20in%20Skin%20Cancer%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/adaptable-near-infrared-spectroscopy-fiber-array-for-improved-coupling-to-different-breast-sizes-dur/"><div class="card-body"> <em class="small" data-ts="1391187600" data-df="ll" > Jan 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Adaptable Near-Infrared Spectroscopy Fiber Array for Improved Coupling to Different Breast Sizes During Clinical MRI</h3><div class="text-muted small"><p> Rationale and Objectives Near-infrared spectroscopy (NIRS) of breast can provide functional information on the vascular and structural compartments of tissues in regions identified during simultan...</p></div></div></a></div><div class="card"> <a href="/posts/advances-in-noninvasive-functional-imaging-of-bone/"><div class="card-body"> <em class="small" data-ts="1391187600" data-df="ll" > Jan 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Advances in Noninvasive Functional Imaging of Bone</h3><div class="text-muted small"><p> The demand for functional imaging in clinical medicine is comprehensive. Although the gold standard for the functional imaging of human bones in clinical settings is still radionuclide-based imagin...</p></div></div></a></div><div class="card"> <a href="/posts/blood-flow-reduction-in-breast-tissue-due-to-mammographic-compression/"><div class="card-body"> <em class="small" data-ts="1391187600" data-df="ll" > Jan 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Blood Flow Reduction in Breast Tissue due to Mammographic Compression</h3><div class="text-muted small"><p> Rationale and objectives This study measures hemodynamic properties such as blood flow and hemoglobin concentration and oxygenation in the healthy human breast under a wide range of compressive lo...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/is-higher-lactate-an-indicator-of-tumor-metastatic-risk-a-pilot-mrs-study-using-hyperpolarized13-c/" class="btn btn-outline-primary" prompt="Older"><p>Is Higher Lactate an Indicator of Tumor Metastatic Risk? A Pilot MRS Study Using Hyperpolarized13 C-Pyruvate</p></a> <a href="/posts/microvascular-versus-macrovascular-cerebral-vasomotor-reactivity-in-patients-with-severe-internal-ca/" class="btn btn-outline-primary" prompt="Newer"><p>Microvascular versus Macrovascular Cerebral Vasomotor Reactivity in Patients with Severe Internal Carotid Artery Stenosis or Occlusion</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
